- We will join with the medical profession to invest in research projects on the immune response to influenza and respiratory viral infections, and strengthen the prevention and treatment of viral threats.
- The Malaysian overseas subsidiary was formally established to expand the Southeast Asian market.
- We will join hands with Taizong Biotech's "Liquid Biopsy" technology to be early diagnose liver cancer tumors and becom pioneer in the liver cancer recurrence detection platform.
- We launched a personalized all-round genetic test and integrate with the "Taiwan Precision Medical Initiative (TPMI)".
- In 2018 first "Personal Genetic Databank" services to five important stage of life as the basis for individuals to create whole genome database.
- The 1st Affymetrix Service Provider certified lab in Taiwan
- The 1st Illumina MiSeq CSPro certified lab in Taiwan
- Granted CAP Accreditation
- Signed Japanese agencies to serve the local market
- Named Deloitte’s 2013 Technology Fast 500 Asia Pacific Companies
- Implemented the 1st Process Management and Compliance (PMC) system for the largest API manufacturer in Taiwan
- Named Deloitte’s 2012 Technology Fast 500 Asia Pacific Companies
- The 1st publicly traded company specializing in genetic diagnosis and scientific informatics in Taiwan with its IPO (4160-TW).
- Winner of the 2011 Corporate Social Responsibility (CSR) Excellence Awards for Taiwanese Small and Medium Enterprises (SMEs)
- Awarded ASSTD (Assist Service Sector Technology Development) grant from Ministry of Economy
- Established Informatics Business Unit
- Winner of the 2010 Promising Enterprise of the Taiwan Healthcare and Agricultural Biotech Industries Innovation and Excellence Awards
- Granted with a Small Business Innovation Research (SBIR) Program from Ministry of Economic Affairs in Taiwan
- The 1st lab to offer PGD service in Taiwan as well as in Asia
- GGA Corp. Founded